Predi-COVID: can we predict COVID-19 prognosis?
Summary
The “Predi-COVID” cohort study aims to identify important risk factors and biomarkers associated with COVID-19 severity, long-term health consequences of the disease and viral escaping natural or induced COVID-19 immunity. This study is led by a consortium of Luxembourgish research institutions, including Luxembourg Institute of Health, Integrated Biobank of Luxembourg, the Laboratoire National de Santé, the University of Luxembourg, the Luxembourg Centre for Systems Biomedicine and the Centre Hospitalier de Luxembourg. The study is co-financed by the Luxembourg National Research Fund (FNR-grant number: 14716273) and by the André Losch Foundation.
Researcher Profile
